GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

ABVC Biopharma ABVC · USD

N/A · US listing · 🇺🇸 United States

Compare

0.97

-2.88%

Close of 5 Nov 2026, in USD

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
Jiang (Shuling)1m8.59%+36.9k28 Apr 2025
YuanGene, Corp829.7k7.11%—27 May 2025
Jiang (Tsung-Shann)376k3.22%−47.2k28 Apr 2025
Jiang (Eugene)131.2k1.12%—10 Jul 2025
The Vanguard Group, Inc.111.5k0.96%+64.6k30 Jun 2025
Geode Capital Management, L.L.C.110.5k0.95%+6k30 Jun 2025
Patil (Uttam)72.4k0.62%—28 Apr 2025
Odaira (Yoshinobu)57.8k0.49%—28 Apr 2025
XTX Markets LLC52.6k0.45%−7.8k30 Jun 2025
Jiang (Chang-Jen)42k0.36%−5028 Apr 2025
Jiang (Tsang Ming)42k0.36%—28 Apr 2025
Chou (Yen-Hsin)42k0.36%—28 Apr 2025
Sakamoto (Norimi)41.9k0.36%—28 Apr 2025
Renaissance Technologies LLC41.7k0.36%+41.7k30 Jun 2025
Miao (Hsin-Hui)41.5k0.36%−6.6k28 Apr 2025

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

589.9k

+20.3% on the period before. 6.9 days to cover.

Short volume

Share of the day's trading sold short, 5 Nov 2026

31.4%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 24 Sept 20264,906 shares
  • 22 Sept 20262,602 shares
  • 21 Sept 20261,919 shares
  • 18 Sept 2026397 shares
  • 15 Sept 2026885 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.